Belgium· BE-AMP-SAM485084-00
Genvoya 150 mg - 150 mg - 200 mg - 10 mg
A emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat product containing cobicistat, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR18 (emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat · ATC J05AR18
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cobicistat
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Belgium (BE)
- ATC code
- J05AR18
- ATC class
- Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 6
3 priced- be_apb4201877EUR 858.71
- be_apb4239745EUR 858.71
- be_apb3381456EUR 858.71
- be_apb7715758
- be_apb7729841
- be_apb7729494
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTYBOSTGilead Sciences Ireland UC, Carrigtohill
- SpainTYBOST 150mg comprimidos recubiertos con peliculaGilead Sciences Ireland Unlimited Company
- FinlandTybostGilead Sciences Ireland UC
- IrelandTybost 150 mg film-coated tabletsGilead Sciences Ireland UC
- NetherlandsTybost 150 mg filmomhulde tablettenGilead Sciences Ireland UC
- PolandTybostGilead Sciences Ireland UC
- SwedenTybost 150 mg Filmdragerad tablettGilead Sciences Ireland UC
- United StatesTybostGilead Sciences, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tybost
- Liechtenstein · Tybost
- Norway · Tybost
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5a6b76b-4d7c-4d5b-9ce0-0034cae273d5 GET /v1/drugs/b5a6b76b-4d7c-4d5b-9ce0-0034cae273d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
"name_fr": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
"name_nl": "Genvoya 150 mg - 150 mg - 200 mg - 10 mg",
"amp_code": "SAM485084-00",
"strengths": [
"150.0000",
"150.0000",
"10.0000",
"200.0000",
"60.0000"
],
"pack_count": 4,
"substances": [
"Cobicistat",
"Elvitegravir",
"Tenofovir Alafenamide Fumarate",
"Tenofovir Alafenamide",
"Emtricitabine",
"Lactose",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Emtricitabine, Tenofovir Alafenamide, Elvitegravir and Cobicistat",
"authorisation_numbers": [
"EU/1/15/1061/001",
"EU/1/15/1061/002"
]
}See everything about emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.